Life-Saving Filter Technology Attracts $7.5 Million from Local Investors

Entities Mentioned

• FDA
• CardioSpectra
• Cordis
• Christopher E. Banas
• Paul Castella
• Volcano
• University of Texas Health Science Center

1. Banas and Castella have a long and impressive history of product development and commercializing medical devices. In 2003, Banas and his partner in Advanced Bio Prosthetic Surfaces, Dr. Julio Palmaz ( inventor of the balloon expandable stent), licensed a unique NITINOL stent technologies to Cordis, a division of Johnson & Johnson. Xenotope Diagnostics' co-founder and CEO, Castella, licensed worldwide manufacturing and sales rights for a unique rapid-test technology developed by Xenetope to Genzyme Corporation in 2004. Then in 2005, Banas and Castella co-founded CardioSpectra, another medical device company, which they sold to Volcano Corporation in late 2007. ... (Read Full Article)

   Bookmark or Share this article

   
   

   Related Articles

   • IVUS Disposable Revenues Increase 46 Percent
   • also categorized in Cardiology
   • Volcano Reports 35 Percent Increase in Quarterly Revenues; Ivus ...
   • also categorized in Cardiology
   • Quantitative analysis on optical properties of human atherosclerosis by using polarization-sensitive optical coherence tomography
   • also categorized in Cardiology
   • Volcano Announces Agreement to Acquire CardioSpectra
   • also mentions Christopher E. Banas
   • Quantifying permeability of glucose in normal and atherosclerotic pig aorta in vitro using optical coherence tomography
   • also categorized in Cardiology

   • Volcano Announces Agreement to Acquire CardioSpectra
   • also mentions CardioSpectra
   • Vision Researchers Query FDA About Updating Requirements For Drug Approval
   • also mentions FDA
   • Spectral-domain OCT wows interventional cardiologists
   • also categorized in Cardiology
   • Innovations in imaging for chronic total occlusions: a glimpse into the future of angiography’s blind-spot
   • also categorized in Cardiology
   • Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist?
   • also categorized in Cardiology

Login to comment.